GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: Example 69 [WO2022208391A1]
Compound class:
Synthetic organic
Comment: Polfurmetinib is the INN for a MEK tyrosine kinase inhibitor with antineoplastic potential, from INN proposed list 133 (10th July 2025). The structure is claimed as Example 69 in Pfizer patent WO2022208391A1 [1]. Pfizer have a brain-penetrant MEK inhibitor (PF-07799544) in clinical development, but its structure has not been disclosed (August 2025).
|
|
Bioactivity Comments |
Inhibits phosphorylation of downstream ERK1/2 in A375 cells (IC50 2 nM) [1]. Inhibitory potencies for polfurmetinib at MEK isozymes are not provided in the patent. |